Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease.

Suppr

超能文献

作者信息

Marek Kenneth, Jennings Danna, Seibyl John

机构信息

Department of Neurology, Institute for Neurogenerative Disorders, New Haven, Connecticut, USA.

出版信息

Adv Neurol. 2003;91:183-91.

PMID:12442677

Abstract

摘要

相似文献

Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease.

Adv Neurol. 2003;91:183-91.

Dopamine receptors in Parkinson's disease: imaging studies.

Adv Neurol. 2003;91:65-71.

Objective measures for the progression of Parkinson's disease.

J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):287. doi: 10.1136/jnnp.74.3.287.

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.

Eur J Nucl Med Mol Imaging. 2002 May;29(5):711-4. doi: 10.1007/s00259-002-0814-5. Epub 2002 Mar 23.

Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding.

J Neurol. 2003 Jan;250(1):83-6. doi: 10.1007/s00415-003-0957-8.

Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease.

JAMA. 2002 Jul 17;288(3):311; author reply 312-3.

Single-photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease.

Eur J Nucl Med. 1994 Jan;21(1):1-5. doi: 10.1007/BF00182298.

Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.

J Nucl Med. 1997 Sep;38(9):1453-9.

Role of dopamine transporter imaging in routine clinical practice.

Mov Disord. 2003 Dec;18(12):1415-23. doi: 10.1002/mds.10592.

Levodopa and the progression of Parkinson's disease.

Curr Neurol Neurosci Rep. 2005 Jul;5(4):261-2. doi: 10.1007/s11910-005-0069-1.

引用本文的文献

Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders.

J Nucl Med. 2022 Jun;63(Suppl 1):27S-32S. doi: 10.2967/jnumed.121.263197.

The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease.

J Parkinsons Dis. 2019;9(3):553-563. doi: 10.3233/JPD-191648.

In vitro imaging techniques in neurodegenerative diseases.

Mol Imaging Biol. 2007 Jul-Aug;9(4):161-75. doi: 10.1007/s11307-007-0088-1.

Surrogate outcomes in neurology, psychiatry, and psychopharmacology.

Dialogues Clin Neurosci. 2006;8(3):345-52. doi: 10.31887/DCNS.2006.8.3/lstaner.

[(11)C]d-threo-methylphenidate PET in patients with Parkinson's disease and essential tremor.

J Neural Transm (Vienna). 2006 Feb;113(2):187-93. doi: 10.1007/s00702-005-0311-7. Epub 2005 Jun 15.

Surrogate endpoints in Parkinson's disease research.

Curr Neurol Neurosci Rep. 2003 Jul;3(4):314-20. doi: 10.1007/s11910-003-0008-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验